HUGO VILLANUEVA to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications HUGO VILLANUEVA has written about Xenograft Model Antitumor Assays.
Connection Strength
0.112
-
Chick Embryo Chorioallantoic Membrane as a Platform for Assessing the In?Vivo Efficacy of Chimeric Antigen Receptor T-cell Therapy in Solid Tumors. Immunohorizons. 2024 08 01; 8(8):598-605.
Score: 0.044
-
In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts. J Mammary Gland Biol Neoplasia. 2022 06; 27(2):211-230.
Score: 0.038
-
Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression. Oncogene. 2020 10; 39(40):6265-6285.
Score: 0.031